UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058702
Receipt number R000067117
Scientific Title Effects of antidiabetic drugs on endogenous insulin secretion in non-insulin-dependent type 1 diabetes mellitus
Date of disclosure of the study information 2025/08/06
Last modified on 2025/08/05 17:48:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of antidiabetic drugs on endogenous insulin secretion in non-insulin-dependent type 1 diabetes mellitus

Acronym

Effects of antidiabetic drugs on endogenous insulin secretion in non-insulin-dependent type 1 diabetes mellitus

Scientific Title

Effects of antidiabetic drugs on endogenous insulin secretion in non-insulin-dependent type 1 diabetes mellitus

Scientific Title:Acronym

Effects of antidiabetic drugs on endogenous insulin secretion in non-insulin-dependent type 1 diabetes mellitus

Region

Japan


Condition

Condition

diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study will identify a population of people who were initially diagnosed with type 2 diabetes and later re-diagnosed with type 1 diabetes, a group presumed to include individuals with features of slowly progressive type 1 diabetes (SPIDDM). The impact of diabetes medications on the trajectory of endogenous insulin secretion will then be examined in this cohort using real world data.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Phase IV


Assessment

Primary outcomes

The number of days from when the disease "type 2 diabetes" was diagnosed to when the disease "type 1 diabetes" was diagnosed (evaluated by whether or not SGLT2 inhibitors were introduced during that period)

Key secondary outcomes

The number of days from when the disease "type 2 diabetes" was diagnosed to when the disease "type 1 diabetes" was diagnosed (evaluated by whether or not SU, DPP-4i, and GLP-1RA were introduced during that period)


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

People who were initially diagnosed with type 2 diabetes (ICD-10 code: E12) and treated with antidiabetic drugs, and then diagnosed with type 1 diabetes (ICD-10 code: E10) between 90 days and less than 10 years after their type 2 diabetes diagnosis and in whom treatment with insulin preparations was initiated

Key exclusion criteria

1.People who developed diabetic ketoacidosis (E101 and E141) or were hospitalized within one month before or after the diagnosis of type 1 diabetes
2.The prescription of both long-acting and rapid-acting or ultra-rapid-acting insulin preparations prior to the diagnosis of type 1 diabetes had already been used.
3.The initiation of SGLT2i treatment followed the diagnosis of type 1 diabetes.

Target sample size

5000


Research contact person

Name of lead principal investigator

1st name Tomohisa
Middle name
Last name Seki

Organization

The University of Tokyo Hospital

Division name

Department of Healthcare Information Management

Zip code

113-8655

Address

7-3-1, hongo, bunkyo-ku, Tokyo

TEL

03-3815-5411

Email

seki@m.u-tokyo.ac.jp


Public contact

Name of contact person

1st name KYUYONG
Middle name
Last name CHO

Organization

Hokkaido University Hospital

Division name

Institute of Health Science Innovation for Medical Care

Zip code

060-8648

Address

N14W5, kita-ku, Sapporo, Hokkaido

TEL

011-706-1161

Homepage URL


Email

kyuyong-cho@pop.med.hokudai.ac.jp


Sponsor or person

Institute

The University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB-A, The University of Tokyo, Graduate School of Medicine / Faculty of Medicine Institutional Review Board

Address

7-3-1, hongo, bunkyo-ku, Tokyo

Tel

03-3815-5411

Email

kyuyong-cho@pop.med.hokudai.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

2025112NI

Org. issuing International ID_1

IRB-A, The University of Tokyo, Graduate School of Medicine / Faculty of Medicine Institutional Review Board

Study ID_2


Org. issuing International ID_2


IND to MHLW

Hokkaido


Institutions

Institutions

東京大学医学部附属病院、北海道大学病院


Other administrative information

Date of disclosure of the study information

2025 Year 08 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2025 Year 05 Month 20 Day

Date of IRB

2025 Year 07 Month 28 Day

Anticipated trial start date

2025 Year 07 Month 28 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2025 Year 08 Month 05 Day

Last modified on

2025 Year 08 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067117